ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Defibrinated Animal Blood Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-4V17947
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Defibrinated Animal Blood Market Research Report 2024
BUY CHAPTERS

Global Defibrinated Animal Blood Market Research Report 2025

Code: QYRE-Auto-4V17947
Report
September 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
E&O Laboratories Ltd
HemoStat Laboratories
TCS Biosciences
SSI Diagnostica
SR Group
Szabo-Scandic
Thermo Fisher Scientific
bioMérieux
Southern Biological
Trafalgar Scientific
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
Rockland Immunochemicals Inc.
LABone Scientific Co.Ltd.
Biowest(BioNordic A/S)
Pel-Freez Biologicals
EWC Diagnostics
Kraeber & Co. GmbH
Bio Nutrientes Do Brasil Ltda.
LAMPIRE Biological Laboratories; Inc.
Quad Five(Materials Bio Inc.)
Guangzhou Ruite Biotechnology Co., Ltd.
OBiO Technology ( Shanghai ) Corp.,Ltd.
Beijing Solarbio Science & Technology Co., Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.

Defibrinated Animal Blood Market Size

The global market for Defibrinated Animal Blood was valued at US$ 329 million in the year 2024 and is projected to reach a revised size of US$ 524 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Defibrinated Animal Blood Market

Defibrinated Animal Blood Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Defibrinated Animal Blood competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global production of defibrinated animal blood reached 3,278,220 kiloliters, with an average selling price of $100.28 per liter. Defibrinated blood products are drawn aseptically from healthy donor animals. The blood is mechanically defibrated and contains no anticoagulants or other additives. All blood is tested for color, platelet count (PCV), and hemolysis prior to pooling. A wide variety of defibrinated blood products exist, depending on the animal source (ovine, equine, bovine, chicken, porcine, etc.) and intended use. Products vary based on the defibrination method used, resulting in varying levels of purity and functionality. Defibrinated ovine blood holds a significant market share due to its widespread use in research settings and compatibility with various experimental models. Defibrinated horse blood is used less frequently than ovine blood and may be used in specific research areas. Defibrinated bovine blood is widely used across various research fields, and its large-scale availability makes it cost-effective for many studies. Defibrinated chicken blood has a niche market with specific applications in research settings, primarily limited to avian research. Defibrinated porcine blood may have a smaller market share due to cost and availability. Other sources include rabbits, mice, and other animals.
North American market for Defibrinated Animal Blood is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Defibrinated Animal Blood is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Defibrinated Animal Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Defibrinated Animal Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Defibrinated Animal Blood.
The Defibrinated Animal Blood market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Defibrinated Animal Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Defibrinated Animal Blood manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Defibrinated Animal Blood Market Report

Report Metric Details
Report Name Defibrinated Animal Blood Market
Accounted market size in year US$ 329 million
Forecasted market size in 2031 US$ 524 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Bovine
  • Horse
  • Rabbit
  • Sheep
  • Others
Segment by Application
  • Biomedicine
  • Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, Inc., LABone Scientific Co.Ltd., Biowest(BioNordic A/S), Pel-Freez Biologicals, EWC Diagnostics, Kraeber & Co. GmbH, Bio Nutrientes Do Brasil Ltda., Lampire Biological Laboratories, Inc., Quad Five(Materials Bio Inc.), Guangzhou Ruite Biotechnology Co., Ltd., Obio Technology (Shanghai) Corp., Ltd., Beijing Solarbio Science & Technology Co.,Ltd., Nanjing SenBeiJia Biological Technology Co., Ltd., Changde BKMAM Biotechnology Co. Ltd., Beijing Baiao Leibo Technology Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Defibrinated Animal Blood manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Defibrinated Animal Blood in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Defibrinated Animal Blood Market growing?

Ans: The Defibrinated Animal Blood Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Defibrinated Animal Blood Market size in 2031?

Ans: The Defibrinated Animal Blood Market size in 2031 will be US$ 524 million.

Who are the main players in the Defibrinated Animal Blood Market report?

Ans: The main players in the Defibrinated Animal Blood Market are Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, Inc., LABone Scientific Co.Ltd., Biowest(BioNordic A/S), Pel-Freez Biologicals, EWC Diagnostics, Kraeber & Co. GmbH, Bio Nutrientes Do Brasil Ltda., Lampire Biological Laboratories, Inc., Quad Five(Materials Bio Inc.), Guangzhou Ruite Biotechnology Co., Ltd., Obio Technology (Shanghai) Corp., Ltd., Beijing Solarbio Science & Technology Co.,Ltd., Nanjing SenBeiJia Biological Technology Co., Ltd., Changde BKMAM Biotechnology Co. Ltd., Beijing Baiao Leibo Technology Co., Ltd.

What are the Application segmentation covered in the Defibrinated Animal Blood Market report?

Ans: The Applications covered in the Defibrinated Animal Blood Market report are Biomedicine, Research

What are the Type segmentation covered in the Defibrinated Animal Blood Market report?

Ans: The Types covered in the Defibrinated Animal Blood Market report are Bovine, Horse, Rabbit, Sheep, Others

1 Defibrinated Animal Blood Market Overview
1.1 Product Definition
1.2 Defibrinated Animal Blood by Type
1.2.1 Global Defibrinated Animal Blood Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bovine
1.2.3 Horse
1.2.4 Rabbit
1.2.5 Sheep
1.2.6 Others
1.3 Defibrinated Animal Blood by Application
1.3.1 Global Defibrinated Animal Blood Market Value by Application (2024 VS 2031)
1.3.2 Biomedicine
1.3.3 Research
1.4 Global Defibrinated Animal Blood Market Size Estimates and Forecasts
1.4.1 Global Defibrinated Animal Blood Revenue 2020-2031
1.4.2 Global Defibrinated Animal Blood Sales 2020-2031
1.4.3 Global Defibrinated Animal Blood Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Defibrinated Animal Blood Market Competition by Manufacturers
2.1 Global Defibrinated Animal Blood Sales Market Share by Manufacturers (2020-2025)
2.2 Global Defibrinated Animal Blood Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Defibrinated Animal Blood Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Defibrinated Animal Blood, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Defibrinated Animal Blood, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Defibrinated Animal Blood, Product Type & Application
2.7 Global Key Manufacturers of Defibrinated Animal Blood, Date of Enter into This Industry
2.8 Global Defibrinated Animal Blood Market Competitive Situation and Trends
2.8.1 Global Defibrinated Animal Blood Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Defibrinated Animal Blood Players Market Share by Revenue
2.8.3 Global Defibrinated Animal Blood Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Defibrinated Animal Blood Market Scenario by Region
3.1 Global Defibrinated Animal Blood Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Defibrinated Animal Blood Sales by Region: 2020-2031
3.2.1 Global Defibrinated Animal Blood Sales by Region: 2020-2025
3.2.2 Global Defibrinated Animal Blood Sales by Region: 2026-2031
3.3 Global Defibrinated Animal Blood Revenue by Region: 2020-2031
3.3.1 Global Defibrinated Animal Blood Revenue by Region: 2020-2025
3.3.2 Global Defibrinated Animal Blood Revenue by Region: 2026-2031
3.4 North America Defibrinated Animal Blood Market Facts & Figures by Country
3.4.1 North America Defibrinated Animal Blood Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Defibrinated Animal Blood Sales by Country (2020-2031)
3.4.3 North America Defibrinated Animal Blood Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Defibrinated Animal Blood Market Facts & Figures by Country
3.5.1 Europe Defibrinated Animal Blood Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Defibrinated Animal Blood Sales by Country (2020-2031)
3.5.3 Europe Defibrinated Animal Blood Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Defibrinated Animal Blood Market Facts & Figures by Region
3.6.1 Asia Pacific Defibrinated Animal Blood Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Defibrinated Animal Blood Sales by Region (2020-2031)
3.6.3 Asia Pacific Defibrinated Animal Blood Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Defibrinated Animal Blood Market Facts & Figures by Country
3.7.1 Latin America Defibrinated Animal Blood Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Defibrinated Animal Blood Sales by Country (2020-2031)
3.7.3 Latin America Defibrinated Animal Blood Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Defibrinated Animal Blood Market Facts & Figures by Country
3.8.1 Middle East and Africa Defibrinated Animal Blood Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Defibrinated Animal Blood Sales by Country (2020-2031)
3.8.3 Middle East and Africa Defibrinated Animal Blood Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Defibrinated Animal Blood Sales by Type (2020-2031)
4.1.1 Global Defibrinated Animal Blood Sales by Type (2020-2025)
4.1.2 Global Defibrinated Animal Blood Sales by Type (2026-2031)
4.1.3 Global Defibrinated Animal Blood Sales Market Share by Type (2020-2031)
4.2 Global Defibrinated Animal Blood Revenue by Type (2020-2031)
4.2.1 Global Defibrinated Animal Blood Revenue by Type (2020-2025)
4.2.2 Global Defibrinated Animal Blood Revenue by Type (2026-2031)
4.2.3 Global Defibrinated Animal Blood Revenue Market Share by Type (2020-2031)
4.3 Global Defibrinated Animal Blood Price by Type (2020-2031)
5 Segment by Application
5.1 Global Defibrinated Animal Blood Sales by Application (2020-2031)
5.1.1 Global Defibrinated Animal Blood Sales by Application (2020-2025)
5.1.2 Global Defibrinated Animal Blood Sales by Application (2026-2031)
5.1.3 Global Defibrinated Animal Blood Sales Market Share by Application (2020-2031)
5.2 Global Defibrinated Animal Blood Revenue by Application (2020-2031)
5.2.1 Global Defibrinated Animal Blood Revenue by Application (2020-2025)
5.2.2 Global Defibrinated Animal Blood Revenue by Application (2026-2031)
5.2.3 Global Defibrinated Animal Blood Revenue Market Share by Application (2020-2031)
5.3 Global Defibrinated Animal Blood Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 TCS Biosciences
6.2.1 TCS Biosciences Company Information
6.2.2 TCS Biosciences Description and Business Overview
6.2.3 TCS Biosciences Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.2.4 TCS Biosciences Defibrinated Animal Blood Product Portfolio
6.2.5 TCS Biosciences Recent Developments/Updates
6.3 BioMérieux
6.3.1 BioMérieux Company Information
6.3.2 BioMérieux Description and Business Overview
6.3.3 BioMérieux Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioMérieux Defibrinated Animal Blood Product Portfolio
6.3.5 BioMérieux Recent Developments/Updates
6.4 E & O Laboratories Ltd
6.4.1 E & O Laboratories Ltd Company Information
6.4.2 E & O Laboratories Ltd Description and Business Overview
6.4.3 E & O Laboratories Ltd Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.4.4 E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio
6.4.5 E & O Laboratories Ltd Recent Developments/Updates
6.5 Southern Biological
6.5.1 Southern Biological Company Information
6.5.2 Southern Biological Description and Business Overview
6.5.3 Southern Biological Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Southern Biological Defibrinated Animal Blood Product Portfolio
6.5.5 Southern Biological Recent Developments/Updates
6.6 Trafalgar Scientific
6.6.1 Trafalgar Scientific Company Information
6.6.2 Trafalgar Scientific Description and Business Overview
6.6.3 Trafalgar Scientific Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Trafalgar Scientific Defibrinated Animal Blood Product Portfolio
6.6.5 Trafalgar Scientific Recent Developments/Updates
6.7 HemoStat Laboratories
6.7.1 HemoStat Laboratories Company Information
6.7.2 HemoStat Laboratories Description and Business Overview
6.7.3 HemoStat Laboratories Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HemoStat Laboratories Defibrinated Animal Blood Product Portfolio
6.7.5 HemoStat Laboratories Recent Developments/Updates
6.8 Dutscher
6.8.1 Dutscher Company Information
6.8.2 Dutscher Description and Business Overview
6.8.3 Dutscher Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dutscher Defibrinated Animal Blood Product Portfolio
6.8.5 Dutscher Recent Developments/Updates
6.9 Serana Europe
6.9.1 Serana Europe Company Information
6.9.2 Serana Europe Description and Business Overview
6.9.3 Serana Europe Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serana Europe Defibrinated Animal Blood Product Portfolio
6.9.5 Serana Europe Recent Developments/Updates
6.10 Innovative Research Inc
6.10.1 Innovative Research Inc Company Information
6.10.2 Innovative Research Inc Description and Business Overview
6.10.3 Innovative Research Inc Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Innovative Research Inc Defibrinated Animal Blood Product Portfolio
6.10.5 Innovative Research Inc Recent Developments/Updates
6.11 Colorado Serum
6.11.1 Colorado Serum Company Information
6.11.2 Colorado Serum Description and Business Overview
6.11.3 Colorado Serum Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Colorado Serum Defibrinated Animal Blood Product Portfolio
6.11.5 Colorado Serum Recent Developments/Updates
6.12 SSI Diagnostica
6.12.1 SSI Diagnostica Company Information
6.12.2 SSI Diagnostica Description and Business Overview
6.12.3 SSI Diagnostica Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.12.4 SSI Diagnostica Defibrinated Animal Blood Product Portfolio
6.12.5 SSI Diagnostica Recent Developments/Updates
6.13 SR Group
6.13.1 SR Group Company Information
6.13.2 SR Group Description and Business Overview
6.13.3 SR Group Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SR Group Defibrinated Animal Blood Product Portfolio
6.13.5 SR Group Recent Developments/Updates
6.14 Szabo-Scandic
6.14.1 Szabo-Scandic Company Information
6.14.2 Szabo-Scandic Description and Business Overview
6.14.3 Szabo-Scandic Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Szabo-Scandic Defibrinated Animal Blood Product Portfolio
6.14.5 Szabo-Scandic Recent Developments/Updates
6.15 Rockland Immunochemicals, Inc.
6.15.1 Rockland Immunochemicals, Inc. Company Information
6.15.2 Rockland Immunochemicals, Inc. Description and Business Overview
6.15.3 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio
6.15.5 Rockland Immunochemicals, Inc. Recent Developments/Updates
6.16 LABone Scientific Co.Ltd.
6.16.1 LABone Scientific Co.Ltd. Company Information
6.16.2 LABone Scientific Co.Ltd. Description and Business Overview
6.16.3 LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.16.4 LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio
6.16.5 LABone Scientific Co.Ltd. Recent Developments/Updates
6.17 Biowest(BioNordic A/S)
6.17.1 Biowest(BioNordic A/S) Company Information
6.17.2 Biowest(BioNordic A/S) Description and Business Overview
6.17.3 Biowest(BioNordic A/S) Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio
6.17.5 Biowest(BioNordic A/S) Recent Developments/Updates
6.18 Pel-Freez Biologicals
6.18.1 Pel-Freez Biologicals Company Information
6.18.2 Pel-Freez Biologicals Description and Business Overview
6.18.3 Pel-Freez Biologicals Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio
6.18.5 Pel-Freez Biologicals Recent Developments/Updates
6.19 EWC Diagnostics
6.19.1 EWC Diagnostics Company Information
6.19.2 EWC Diagnostics Description and Business Overview
6.19.3 EWC Diagnostics Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.19.4 EWC Diagnostics Defibrinated Animal Blood Product Portfolio
6.19.5 EWC Diagnostics Recent Developments/Updates
6.20 Kraeber & Co. GmbH
6.20.1 Kraeber & Co. GmbH Company Information
6.20.2 Kraeber & Co. GmbH Description and Business Overview
6.20.3 Kraeber & Co. GmbH Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio
6.20.5 Kraeber & Co. GmbH Recent Developments/Updates
6.21 Bio Nutrientes Do Brasil Ltda.
6.21.1 Bio Nutrientes Do Brasil Ltda. Company Information
6.21.2 Bio Nutrientes Do Brasil Ltda. Description and Business Overview
6.21.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio
6.21.5 Bio Nutrientes Do Brasil Ltda. Recent Developments/Updates
6.22 Lampire Biological Laboratories, Inc.
6.22.1 Lampire Biological Laboratories, Inc. Company Information
6.22.2 Lampire Biological Laboratories, Inc. Description and Business Overview
6.22.3 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio
6.22.5 Lampire Biological Laboratories, Inc. Recent Developments/Updates
6.23 Quad Five(Materials Bio Inc.)
6.23.1 Quad Five(Materials Bio Inc.) Company Information
6.23.2 Quad Five(Materials Bio Inc.) Description and Business Overview
6.23.3 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio
6.23.5 Quad Five(Materials Bio Inc.) Recent Developments/Updates
6.24 Guangzhou Ruite Biotechnology Co., Ltd.
6.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
6.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Description and Business Overview
6.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio
6.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments/Updates
6.25 Obio Technology (Shanghai) Corp., Ltd.
6.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
6.25.2 Obio Technology (Shanghai) Corp., Ltd. Description and Business Overview
6.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio
6.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments/Updates
6.26 Beijing Solarbio Science & Technology Co.,Ltd.
6.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
6.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Description and Business Overview
6.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio
6.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments/Updates
6.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
6.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
6.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Description and Business Overview
6.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
6.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments/Updates
6.28 Changde BKMAM Biotechnology Co. Ltd.
6.28.1 Changde BKMAM Biotechnology Co. Ltd. Company Information
6.28.2 Changde BKMAM Biotechnology Co. Ltd. Description and Business Overview
6.28.3 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio
6.28.5 Changde BKMAM Biotechnology Co. Ltd. Recent Developments/Updates
6.29 Beijing Baiao Leibo Technology Co., Ltd.
6.29.1 Beijing Baiao Leibo Technology Co., Ltd. Company Information
6.29.2 Beijing Baiao Leibo Technology Co., Ltd. Description and Business Overview
6.29.3 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
6.29.5 Beijing Baiao Leibo Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Defibrinated Animal Blood Industry Chain Analysis
7.2 Defibrinated Animal Blood Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Defibrinated Animal Blood Production Mode & Process Analysis
7.4 Defibrinated Animal Blood Sales and Marketing
7.4.1 Defibrinated Animal Blood Sales Channels
7.4.2 Defibrinated Animal Blood Distributors
7.5 Defibrinated Animal Blood Customer Analysis
8 Defibrinated Animal Blood Market Dynamics
8.1 Defibrinated Animal Blood Industry Trends
8.2 Defibrinated Animal Blood Market Drivers
8.3 Defibrinated Animal Blood Market Challenges
8.4 Defibrinated Animal Blood Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
E&O Laboratories Ltd
HemoStat Laboratories
TCS Biosciences
SSI Diagnostica
SR Group
Szabo-Scandic
Thermo Fisher Scientific
bioMérieux
Southern Biological
Trafalgar Scientific
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
Rockland Immunochemicals Inc.
LABone Scientific Co.Ltd.
Biowest(BioNordic A/S)
Pel-Freez Biologicals
EWC Diagnostics
Kraeber & Co. GmbH
Bio Nutrientes Do Brasil Ltda.
LAMPIRE Biological Laboratories; Inc.
Quad Five(Materials Bio Inc.)
Guangzhou Ruite Biotechnology Co., Ltd.
OBiO Technology ( Shanghai ) Corp.,Ltd.
Beijing Solarbio Science & Technology Co., Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.
List of Tables
 Table 1. Global Defibrinated Animal Blood Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Defibrinated Animal Blood Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Defibrinated Animal Blood Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Defibrinated Animal Blood Sales (KL) of Key Manufacturers (2020-2025)
 Table 5. Global Defibrinated Animal Blood Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Defibrinated Animal Blood Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Defibrinated Animal Blood Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Defibrinated Animal Blood Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Defibrinated Animal Blood, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Defibrinated Animal Blood, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Defibrinated Animal Blood, Product Type & Application
 Table 12. Global Key Manufacturers of Defibrinated Animal Blood, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Defibrinated Animal Blood by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Defibrinated Animal Blood as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Defibrinated Animal Blood Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Defibrinated Animal Blood Sales by Region (2020-2025) & (KL)
 Table 18. Global Defibrinated Animal Blood Sales Market Share by Region (2020-2025)
 Table 19. Global Defibrinated Animal Blood Sales by Region (2026-2031) & (KL)
 Table 20. Global Defibrinated Animal Blood Sales Market Share by Region (2026-2031)
 Table 21. Global Defibrinated Animal Blood Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Defibrinated Animal Blood Revenue Market Share by Region (2020-2025)
 Table 23. Global Defibrinated Animal Blood Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Defibrinated Animal Blood Revenue Market Share by Region (2026-2031)
 Table 25. North America Defibrinated Animal Blood Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Defibrinated Animal Blood Sales by Country (2020-2025) & (KL)
 Table 27. North America Defibrinated Animal Blood Sales by Country (2026-2031) & (KL)
 Table 28. North America Defibrinated Animal Blood Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Defibrinated Animal Blood Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Defibrinated Animal Blood Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Defibrinated Animal Blood Sales by Country (2020-2025) & (KL)
 Table 32. Europe Defibrinated Animal Blood Sales by Country (2026-2031) & (KL)
 Table 33. Europe Defibrinated Animal Blood Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Defibrinated Animal Blood Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Defibrinated Animal Blood Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Defibrinated Animal Blood Sales by Region (2020-2025) & (KL)
 Table 37. Asia Pacific Defibrinated Animal Blood Sales by Region (2026-2031) & (KL)
 Table 38. Asia Pacific Defibrinated Animal Blood Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Defibrinated Animal Blood Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Defibrinated Animal Blood Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Defibrinated Animal Blood Sales by Country (2020-2025) & (KL)
 Table 42. Latin America Defibrinated Animal Blood Sales by Country (2026-2031) & (KL)
 Table 43. Latin America Defibrinated Animal Blood Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Defibrinated Animal Blood Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Defibrinated Animal Blood Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Defibrinated Animal Blood Sales by Country (2020-2025) & (KL)
 Table 47. Middle East and Africa Defibrinated Animal Blood Sales by Country (2026-2031) & (KL)
 Table 48. Middle East and Africa Defibrinated Animal Blood Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Defibrinated Animal Blood Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Defibrinated Animal Blood Sales (KL) by Type (2020-2025)
 Table 51. Global Defibrinated Animal Blood Sales (KL) by Type (2026-2031)
 Table 52. Global Defibrinated Animal Blood Sales Market Share by Type (2020-2025)
 Table 53. Global Defibrinated Animal Blood Sales Market Share by Type (2026-2031)
 Table 54. Global Defibrinated Animal Blood Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Defibrinated Animal Blood Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Defibrinated Animal Blood Revenue Market Share by Type (2020-2025)
 Table 57. Global Defibrinated Animal Blood Revenue Market Share by Type (2026-2031)
 Table 58. Global Defibrinated Animal Blood Price (US$/L) by Type (2020-2025)
 Table 59. Global Defibrinated Animal Blood Price (US$/L) by Type (2026-2031)
 Table 60. Global Defibrinated Animal Blood Sales (KL) by Application (2020-2025)
 Table 61. Global Defibrinated Animal Blood Sales (KL) by Application (2026-2031)
 Table 62. Global Defibrinated Animal Blood Sales Market Share by Application (2020-2025)
 Table 63. Global Defibrinated Animal Blood Sales Market Share by Application (2026-2031)
 Table 64. Global Defibrinated Animal Blood Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Defibrinated Animal Blood Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Defibrinated Animal Blood Revenue Market Share by Application (2020-2025)
 Table 67. Global Defibrinated Animal Blood Revenue Market Share by Application (2026-2031)
 Table 68. Global Defibrinated Animal Blood Price (US$/L) by Application (2020-2025)
 Table 69. Global Defibrinated Animal Blood Price (US$/L) by Application (2026-2031)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Scientific Defibrinated Animal Blood Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. TCS Biosciences Company Information
 Table 76. TCS Biosciences Description and Business Overview
 Table 77. TCS Biosciences Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. TCS Biosciences Defibrinated Animal Blood Product
 Table 79. TCS Biosciences Recent Developments/Updates
 Table 80. BioMérieux Company Information
 Table 81. BioMérieux Description and Business Overview
 Table 82. BioMérieux Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. BioMérieux Defibrinated Animal Blood Product
 Table 84. BioMérieux Recent Developments/Updates
 Table 85. E & O Laboratories Ltd Company Information
 Table 86. E & O Laboratories Ltd Description and Business Overview
 Table 87. E & O Laboratories Ltd Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. E & O Laboratories Ltd Defibrinated Animal Blood Product
 Table 89. E & O Laboratories Ltd Recent Developments/Updates
 Table 90. Southern Biological Company Information
 Table 91. Southern Biological Description and Business Overview
 Table 92. Southern Biological Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 93. Southern Biological Defibrinated Animal Blood Product
 Table 94. Southern Biological Recent Developments/Updates
 Table 95. Trafalgar Scientific Company Information
 Table 96. Trafalgar Scientific Description and Business Overview
 Table 97. Trafalgar Scientific Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 98. Trafalgar Scientific Defibrinated Animal Blood Product
 Table 99. Trafalgar Scientific Recent Developments/Updates
 Table 100. HemoStat Laboratories Company Information
 Table 101. HemoStat Laboratories Description and Business Overview
 Table 102. HemoStat Laboratories Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 103. HemoStat Laboratories Defibrinated Animal Blood Product
 Table 104. HemoStat Laboratories Recent Developments/Updates
 Table 105. Dutscher Company Information
 Table 106. Dutscher Description and Business Overview
 Table 107. Dutscher Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 108. Dutscher Defibrinated Animal Blood Product
 Table 109. Dutscher Recent Developments/Updates
 Table 110. Serana Europe Company Information
 Table 111. Serana Europe Description and Business Overview
 Table 112. Serana Europe Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 113. Serana Europe Defibrinated Animal Blood Product
 Table 114. Serana Europe Recent Developments/Updates
 Table 115. Innovative Research Inc Company Information
 Table 116. Innovative Research Inc Description and Business Overview
 Table 117. Innovative Research Inc Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 118. Innovative Research Inc Defibrinated Animal Blood Product
 Table 119. Innovative Research Inc Recent Developments/Updates
 Table 120. Colorado Serum Company Information
 Table 121. Colorado Serum Description and Business Overview
 Table 122. Colorado Serum Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 123. Colorado Serum Defibrinated Animal Blood Product
 Table 124. Colorado Serum Recent Developments/Updates
 Table 125. SSI Diagnostica Company Information
 Table 126. SSI Diagnostica Description and Business Overview
 Table 127. SSI Diagnostica Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 128. SSI Diagnostica Defibrinated Animal Blood Product
 Table 129. SSI Diagnostica Recent Developments/Updates
 Table 130. SR Group Company Information
 Table 131. SR Group Description and Business Overview
 Table 132. SR Group Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 133. SR Group Defibrinated Animal Blood Product
 Table 134. SR Group Recent Developments/Updates
 Table 135. Szabo-Scandic Company Information
 Table 136. Szabo-Scandic Description and Business Overview
 Table 137. Szabo-Scandic Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 138. Szabo-Scandic Defibrinated Animal Blood Product
 Table 139. Szabo-Scandic Recent Developments/Updates
 Table 140. Rockland Immunochemicals, Inc. Company Information
 Table 141. Rockland Immunochemicals, Inc. Description and Business Overview
 Table 142. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 143. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product
 Table 144. Rockland Immunochemicals, Inc. Recent Developments/Updates
 Table 145. LABone Scientific Co.Ltd. Company Information
 Table 146. LABone Scientific Co.Ltd. Description and Business Overview
 Table 147. LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 148. LABone Scientific Co.Ltd. Defibrinated Animal Blood Product
 Table 149. LABone Scientific Co.Ltd. Recent Developments/Updates
 Table 150. Biowest(BioNordic A/S) Company Information
 Table 151. Biowest(BioNordic A/S) Description and Business Overview
 Table 152. Biowest(BioNordic A/S) Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 153. Biowest(BioNordic A/S) Defibrinated Animal Blood Product
 Table 154. Biowest(BioNordic A/S) Recent Developments/Updates
 Table 155. Pel-Freez Biologicals Company Information
 Table 156. Pel-Freez Biologicals Description and Business Overview
 Table 157. Pel-Freez Biologicals Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 158. Pel-Freez Biologicals Defibrinated Animal Blood Product
 Table 159. Pel-Freez Biologicals Recent Developments/Updates
 Table 160. EWC Diagnostics Company Information
 Table 161. EWC Diagnostics Description and Business Overview
 Table 162. EWC Diagnostics Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 163. EWC Diagnostics Defibrinated Animal Blood Product
 Table 164. EWC Diagnostics Recent Developments/Updates
 Table 165. Kraeber & Co. GmbH Company Information
 Table 166. Kraeber & Co. GmbH Description and Business Overview
 Table 167. Kraeber & Co. GmbH Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 168. Kraeber & Co. GmbH Defibrinated Animal Blood Product
 Table 169. Kraeber & Co. GmbH Recent Developments/Updates
 Table 170. Bio Nutrientes Do Brasil Ltda. Company Information
 Table 171. Bio Nutrientes Do Brasil Ltda. Description and Business Overview
 Table 172. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 173. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product
 Table 174. Bio Nutrientes Do Brasil Ltda. Recent Developments/Updates
 Table 175. Lampire Biological Laboratories, Inc. Company Information
 Table 176. Lampire Biological Laboratories, Inc. Description and Business Overview
 Table 177. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 178. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product
 Table 179. Lampire Biological Laboratories, Inc. Recent Developments/Updates
 Table 180. Quad Five(Materials Bio Inc.) Company Information
 Table 181. Quad Five(Materials Bio Inc.) Description and Business Overview
 Table 182. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 183. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product
 Table 184. Quad Five(Materials Bio Inc.) Recent Developments/Updates
 Table 185. Guangzhou Ruite Biotechnology Co., Ltd. Company Information
 Table 186. Guangzhou Ruite Biotechnology Co., Ltd. Description and Business Overview
 Table 187. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 188. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product
 Table 189. Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments/Updates
 Table 190. Obio Technology (Shanghai) Corp., Ltd. Company Information
 Table 191. Obio Technology (Shanghai) Corp., Ltd. Description and Business Overview
 Table 192. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 193. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product
 Table 194. Obio Technology (Shanghai) Corp., Ltd. Recent Developments/Updates
 Table 195. Beijing Solarbio Science & Technology Co.,Ltd. Company Information
 Table 196. Beijing Solarbio Science & Technology Co.,Ltd. Description and Business Overview
 Table 197. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 198. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product
 Table 199. Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments/Updates
 Table 200. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
 Table 201. Nanjing SenBeiJia Biological Technology Co., Ltd. Description and Business Overview
 Table 202. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 203. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product
 Table 204. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments/Updates
 Table 205. Changde BKMAM Biotechnology Co. Ltd. Company Information
 Table 206. Changde BKMAM Biotechnology Co. Ltd. Description and Business Overview
 Table 207. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 208. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product
 Table 209. Changde BKMAM Biotechnology Co. Ltd. Recent Developments/Updates
 Table 210. Beijing Baiao Leibo Technology Co., Ltd. Company Information
 Table 211. Beijing Baiao Leibo Technology Co., Ltd. Description and Business Overview
 Table 212. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 213. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product
 Table 214. Beijing Baiao Leibo Technology Co., Ltd. Recent Developments/Updates
 Table 215. Key Raw Materials Lists
 Table 216. Raw Materials Key Suppliers Lists
 Table 217. Defibrinated Animal Blood Distributors List
 Table 218. Defibrinated Animal Blood Customers List
 Table 219. Defibrinated Animal Blood Market Trends
 Table 220. Defibrinated Animal Blood Market Drivers
 Table 221. Defibrinated Animal Blood Market Challenges
 Table 222. Defibrinated Animal Blood Market Restraints
 Table 223. Research Programs/Design for This Report
 Table 224. Key Data Information from Secondary Sources
 Table 225. Key Data Information from Primary Sources
 Table 226. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Defibrinated Animal Blood
 Figure 2. Global Defibrinated Animal Blood Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Defibrinated Animal Blood Market Share by Type: 2024 & 2031
 Figure 4. Bovine Product Picture
 Figure 5. Horse Product Picture
 Figure 6. Rabbit Product Picture
 Figure 7. Sheep Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Defibrinated Animal Blood Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Defibrinated Animal Blood Market Share by Application: 2024 & 2031
 Figure 11. Biomedicine
 Figure 12. Research
 Figure 13. Global Defibrinated Animal Blood Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Defibrinated Animal Blood Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Defibrinated Animal Blood Sales (2020-2031) & (KL)
 Figure 16. Global Defibrinated Animal Blood Average Price (US$/L) & (2020-2031)
 Figure 17. Defibrinated Animal Blood Report Years Considered
 Figure 18. Defibrinated Animal Blood Sales Share by Manufacturers in 2024
 Figure 19. Global Defibrinated Animal Blood Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Defibrinated Animal Blood Players: Market Share by Revenue in Defibrinated Animal Blood in 2024
 Figure 21. Defibrinated Animal Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Defibrinated Animal Blood Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Defibrinated Animal Blood Sales Market Share by Country (2020-2031)
 Figure 24. North America Defibrinated Animal Blood Revenue Market Share by Country (2020-2031)
 Figure 25. United States Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Defibrinated Animal Blood Sales Market Share by Country (2020-2031)
 Figure 28. Europe Defibrinated Animal Blood Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Defibrinated Animal Blood Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Defibrinated Animal Blood Revenue Market Share by Region (2020-2031)
 Figure 36. China Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Defibrinated Animal Blood Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Defibrinated Animal Blood Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Defibrinated Animal Blood Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Defibrinated Animal Blood Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Defibrinated Animal Blood Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Defibrinated Animal Blood by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Defibrinated Animal Blood by Type (2020-2031)
 Figure 56. Global Defibrinated Animal Blood Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Defibrinated Animal Blood by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Defibrinated Animal Blood by Application (2020-2031)
 Figure 59. Global Defibrinated Animal Blood Price (US$/L) by Application (2020-2031)
 Figure 60. Defibrinated Animal Blood Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions